The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Tetraiodothyroacetic acid, a small molecule integrin ligand, blocks angiogenesis induced by vascular endothelial growth factor and basic fibroblast growth factor
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Angiopoietins: a link between angiogenesis and inflammation
Fiedler, U., & Augustin, H. G. (2006) · Trends in Immunology · doi:10.1016/j.it.2006.10.004 · Cited by 606
Research works printed but not linked: 34
- Davis FB, Mousa SA, O′Connor L et al (2004) Proangiogenic action of thyroid hormone is fibroblast growth factor-dependent and is initiated at the cell surface. Circ Res 94:1500–1556 · DOI · Paper page
- Mousa SA, O′Connor L, Davis FB et al (2006) Proangiogenesis action of the thyroid hormone analog 3,5-diiodothyropropionic acid (DITPA) is initiated at the cell surface and is integrin mediated. Endocrinology 147:1602–1607 · DOI
- Mousa SA, O′Connor LJ, Bergh JJ et al (2005) The proangiogenic action of thyroid hormone analogue GC-1 is initiated at an integrin. J Cardiovasc Pharmacol 46:356–360 · DOI · Paper page
- Mousa SA, Mohamed S, Davis PJ et al (2006) Pro-angiogenesis action of thyroid hormone and analogs in a three-dimensional in vitro microvascular endothelial sprouting model. Int Angiol 25:407–413
- Bergh JJ, Lin HY, Lansing L et al (2005) Integrin alphaVbeta3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis. Endocrinology 146:2864–2871 · DOI · Paper page
- Wu SY, Green WL, Huang WS et al (2005) Alternate pathways of thyroid hormone metabolism. Thyroid 15:943–958 · DOI · Paper page
- Davis PJ, Shih A, Lin HY et al (2000) Thyroxine promotes association of mitogen-activated protein kinase and nuclear thyroid hormone receptor (TR) and causes serine phosphorylation of TR. J Biol Chem 275:38032–38039 · DOI · Paper page
- Tang HY, Lin HY, Zhang S et al (2004) Thyroid hormone causes mitogen-activated protein kinase-dependent phosphorylation of the nuclear estrogen receptor. Endocrinology 145:3265–3272 · DOI · Paper page
- Davis FB, Tang HY, Shih A, Keating T et al (2006) Acting via a cell surface receptor, thyroid hormone is a growth factor for glioma cells. Cancer Res 66:7270–7275 · DOI · Paper page
- Plow EF, Haas TA, Zhang L et al (2000) Ligand binding to integrins. J Biol Chem 275:21785–21788 · DOI · Paper page
- Giannone G, Dubin-Thaler BJ, Dobereiner HG et al (2004) Periodic lamellipodial contractions correlate with rearward actin waves. Cell 116:431–443 · DOI · Paper page
- Ridley AJ (2004) Pulling back to move forward. Cell 116:357–358 · DOI
- Arnaout MA, Mahalingam B, Xiong JP (2005) Integrin structure, allostery, and bidirectional signaling. Annu Rev Cell Dev Biol 21:381–410 · DOI · Paper page
- Mahabeleshwar GH, Feng W, Phillips DR et al (2006) Integrin signaling is critical for pathological angiogenesis. J Exp Med 203:2495–2507 · DOI · Paper page
- Soldi R, Mitola S, Strasly M et al (1999) Role of αVβ3 integrin in the activation of vascular endothelial growth factor receptor-2. EMBO J 18:882–892 · DOI · Paper page
- Masson-Gadais B, Houle F, Laferriere J et al (2003) Integrin αVβ3, requirement for VEGFR2-mediated activation of SAPK2/p38 and Hsp90-dependent phosphorylation of focal adhesion kinase in endothelial cells activated by VEGF. Cell Stress Chaperones 8:37–52 · doi:10.1379/1466-1268(2003)8
- Rawlings NG, Simko E, Bebchuk T et al (2003) Localization of integrin αVβ3 and vascular endothelial growth factor receptor-2 (KDR/Flk-1) in cutaneous and oral melanomas of dog. Histol Histopathol 18:819–826
- Davis PJ, Davis FB, Cody V (2005) Membrane receptors mediating thyroid hormone action. Trends Endocrinol Metab 16:429–435 · DOI · Paper page
- Cody V, Davis PJ, Davis FB (2007) Molecular modeling of the thyroid hormone interactions with alphavbeta3 integrin. Steroids 72:165–170 · DOI
- Ausprunk DH, Knighton DR, Folkman J (1975) Vascularization of normal and neoplastic tissues grafted to the chick chorioallantoic. Role of host and preexisting graft blood vessels. Am J Pathol 79:597–628
- Nehls V, Drenckhahn D (1995) A microcarrier-based cocultivation system for the investigation of factors and cells involved in angiogenesis in three-dimensional fibrin matrices in vitro. Histochem Cell Biol 104:459–466 · DOI
- Nehls V, Drenckhahn D (1995) A novel, microcarrier-based in vitro assay for rapid and reliable quantification of three-dimensional cell migration and angiogenesis. Microvasc Res 50:311–322 · DOI · Paper page
- Powell JA, Mohamed SN, Kerr JS et al (2000) Antiangiogenesis efficacy of nitric oxide donors. J Cell Biochem 80(1):104–114 · DOI
- Kerbel RS (2006) Antiangiogenic therapy: a universal chemosensitization strategy for cancer? Science 312:1171–1175 · DOI · Paper page
- Persano L, Crescenzi M, Indraccolo S (2007) Anti-angiogenic gene therapy of cancer: current status and future prospects. Mol Aspects Med 28:87–114 · DOI
- Folkman J (2006) Antiangiogenesis in cancer therapy—endostatin and its mechanisms of action. Exp Cell Res 312:594–607 · DOI · Paper page
- Vredenburgh JJ, Desjardins A, Herndon JE et al (2007) Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma. Clin Cancer Res 13:1253–1259 · DOI · Paper page
- Motzer RJ, Hutson TE, Tomczak P et al (2007) Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med 356:115–124 · DOI · Paper page
- Escudier B, Eisen T, Stadler WM et al (2007) Sorafenib in advanced clear-cell renal-cell carcinoma. N Engl J Med 356:125–134 · DOI · Paper page
- Tsutsui S, Inoue H, Yasuda K et al (2006) Angiopoietin 2 expression in invasive ductal carcinoma of the breast: its relationship to the VEGF expression and microvessel density. Breast Cancer Res Treat 98:261–266 · DOI
- Yoshiji H, Kuriyama S, Noguchi R et al (2005) Angiopoietin 2 displays a vascular endothelial growth factor dependent synergistic effect in hepatocellular carcinoma development in mice. Gut 54:1768–1775 · DOI
- Mandriota SJ, Pepper MS (1998) Regulation of angiopoietin-2 mRNA levels in bovine microvascular endothelial cells by cytokines and hypoxia. Circ Res 83:852–859 · DOI · Paper page
- Pittman CS, Shimizu T, Burger A et al (1980) The non de-iodinative pathways of thyroxine metabolism: 3,5,3′,5-tetraiodothyroacetic acid turnover in normal and fasting human subjects. J Clin Endocrinol Metab 50:712–716 · DOI
- Lin HY, Tang HY, Shih A et al (2007) Thyroid hormone is a MAPK-dependent growth factor for thyroid cancer cells and is anti-apoptotic. Steroids 72:180–187 · DOI
Cited by
Molecular Aspects of Thyroid Hormone Actions
Cheng, S.-Y., Leonard, J. L., & Davis, P. J. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0007 · Cited by 1,384
Self-citationBiomedical Nanomagnetics: A Spin Through Possibilities in Imaging, Diagnostics, and Therapy
Krishnan, K. M. (2010) · IEEE Transactions on Magnetics · doi:10.1109/tmag.2010.2046907 · Cited by 819
Huang, D., Sun, L., Huang, L., & Chen, Y. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11020124 · Cited by 176
Thyroxine promotes lung cancer growth in an orthotopic mouse model
Latteyer, S., Christoph, S., Theurer, S., Hönes, G. S., Schmid, K. W., Führer, D., & Moeller, L. C. (2019) · Endocrine-Related Cancer · doi:10.1530/erc-18-0353 · Cited by 31
Tissue thyroid hormones and thyronamines
Accorroni, A., Saponaro, F., & Zucchi, R. (2016) · Heart Failure Reviews · doi:10.1007/s10741-016-9553-8 · Cited by 29
Metadata
- Authors
- Mousa, S. A., Bergh, J. J., Dier, E., Rebbaa, A., O’Connor, L. J., Yalcin, M., Aljada, A., Dyskin, E., Davis, F. B., Lin, H.-Y., & Davis, P. J.
- Venue
- Angiogenesis
- Published
- 2007-12-13
- Volume
- 11
- Issue
- 2
- Pages
- 183-190
- ISSN
- 0969-6970
- 1573-7209
- Cited by
- 87
- References
- 1
- Language
- en
- Licence
- www.springer.com/tdm (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Tetraiodothyroacetic acid, a small molecule integrin ligand, blocks angiogenesis induced by vascular endothelial growth factor and basic fibroblast growth factor. https://app.cochat.ai/papers/10.1007/s10456-007-9088-7
- The paper
- Mousa, S. A., Bergh, J. J., Dier, E., Rebbaa, A., O’Connor, L. J., Yalcin, M., Aljada, A., Dyskin, E., Davis, F. B., Lin, H.-Y., & Davis, P. J. (2008). Tetraiodothyroacetic acid, a small molecule integrin ligand, blocks angiogenesis induced by vascular endothelial growth factor and basic fibroblast growth factor. Angiogenesis. https://doi.org/10.1007/s10456-007-9088-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.